Navigation Links
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Date:3/23/2009

rtnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

    Contacts:  Jack Lief                                   Mary Claire Duch
               President and CEO                           WeissComm Partners
                                                           Media Relations
               David Walsey                                212.301.7228
               Senior Director, Corporate Communications

               Arena Pharmaceuticals, Inc.
               858.453.7200, ext. 1682


'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
(Date:8/26/2014)... , August 26, 2014 , ... hospitals with surgery validation using its Stratasys Objet24 and Objet30 ... surgery on 3D printed models prior to operations reduces theatre ... effective aid for both patient and surgeon   ... a global leader of 3D printing and additive manufacturing solutions, ...
(Date:8/26/2014)... AVENTURA. Fla. , Aug. 26, 2014 /PRNewswire/ ... trades under the symbol (NUUU) has two (2) ... Inc. Our two subsidiaries harness scientifically advanced technology ... NUUU,s Renuell Int,l, Inc. ... breakthrough anti-aging skin care products that is made ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, Inc. ... Generation Dx Summit; Moving Assays to the Clinic ... and Monitoring of Cell Free Tumor DNA in ... component of its Precision Cancer Monitoring (PCM) platform ... sensitivity for the detection of tumor DNA mutations ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... The Renewable Energy ... promising locations for renewable energy projects. ,The Atlas is the first tool of its kind ... select from a suite of renewable energy options including biomass, efficiency, geothermal, hydroelectric, solar and ... (PRWEB) ...
... ... Environmental Sustainability (EStar) award from the U.S. Department of Energy,s (DOE) Office of Science. ... Argonne, ... Gene/P supercomputer was recognized with an Environmental Sustainability (EStar) award from the U.S. Department ...
... ... of 2007 and to enhance patient safety with complete part traceability, can now use ... coding, scan and software tracking of each part and batch, including all leak test, ... ...
Cached Biology Technology:Vermont Launches Renewable Energy Atlas 2Vermont Launches Renewable Energy Atlas 3Vermont Launches Renewable Energy Atlas 4EStar Award Recognizes Innovative Supercomputer Cooling 2EStar Award Recognizes Innovative Supercomputer Cooling 3InterTech Development Company UDI System Announced 2
(Date:8/25/2014)... predominant strain of community-acquired methicillin-resistant Staphylococcus aureus ... East and northern Africa derived from a single ... this week in mBio , the online ... , CA-MRSA refers to MRSA infections occurring in ... which are typically skin infections, can be transmitted ...
(Date:8/25/2014)... deficiency is one of the most widespread causes of ... the United States are plagued by boron deficient soil ... supplement their soil with boron; however, little is known ... essential nutrient. Now, researchers at the University of Missouri ... development and reproduction in corn plants. Scientists anticipate that ...
(Date:8/25/2014)... that toxic effects of substances known as endocrine ... human-made materials, can pass from one generation to ... with ancestral exposure to EDC may show especially ... new study by researchers from The University of ... and female rats are affected differently by ancestral ...
Breaking Biology News(10 mins):Common European MRSA originated in Africa 2Researchers find boron facilitates stem cell growth and development in corn 2Exposure to toxins makes great granddaughters more susceptible to stress 2
... CITY People at risk for a certain form of ... better chance at surviving or even avoiding the diseases, thanks ... Institute at LDS Hospital. The Intermountain Heathcare group of ... cost-effective way to identify patients who may have Lynch syndrome, ...
... of researchers at the Department of Energy,s BioEnergy Science ... controls ethanol production capacity in a microorganism. This discovery ... that produce higher concentrations of ethanol at lower costs. ... the scientific discoveries of its labs and research centers ...
... study by an international team including professor John Graves of ... species of tunas and billfishes are threatened and in need ... issue of Science magazine,s Policy Forumis the first ... of the International Union for Conservation of Nature (IUCN). ,The ...
Cached Biology News:Study: New process that can save at-risk cancer patients is effective and significantly less costly 2Study: New process that can save at-risk cancer patients is effective and significantly less costly 3Single, key gene discovery could streamline production of biofuels 2Study helps assess global status of tuna and billfish stocks 2Study helps assess global status of tuna and billfish stocks 3
Acetylcholinesterase from human and monkey....
...
... Dye runs faster than Bromophenol blue,or ... gels.,Orange G dye migrates with DNA ... migration at this size,prevents the obscuring ... the front of DNA migration.,The Orange ...
... Gel loading solution, ... for non-denaturing polyacrylamide and ... nucleic acids and offers ... tracking dyes (bromphenol blue ...
Biology Products: